Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/21/15 → 8/21/19 |
Funding
- Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1160-189)
Protocol #1160-189: Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, oral b.i.d.) Versus Acetylsalicylic Acid (100 mg oral q.d.) in
- Bernstein, Richard A (PD/PI)
- Caprio, Fan Z (PD/PI)
Project: Research project